|Articles|October 1, 2021

In case you missed it: Sept. 27 to Oct. 1

It's been a busy week for the Contemporary OB/GYN® team.

Here's what you missed this week on Contemporary OB/GYN®:

Screening for sexual infections critical as cases rise

Not only are chlamydia and gonorrhea 2 of the most common sexually transmitted infections (STIs) in the United States, but people are being diagnosed with them at a higher rate than ever before, according to the Centers for Disease Control and Prevention (CDC).

Uptake of NIPT lower in disadvantaged neighborhoods

Noninvasive prenatal testing (NIPT) uptake is significantly lower in socioeconomically disadvantaged neighborhoods compared to all other neighborhoods in the Netherlands, according to a study in the journal Prenatal Diagnosis.

No specific dietary adjustments increase quality of life in endometriosis patients

An online explorative observational study in the journal Reproductive BioMedicine Online has found that there are no specific dietary adjustments to increase quality of life among Dutch endometriosis patients.

More pregnant women using cannabis amid pandemic

A study released in JAMA reveals a 25% increase in cannabis use in pregnant women during the pandemic in the United States.

Intervention fails to improve teen-to-teen contraceptive communication

Remote delivery of the SpeakOut intervention failed to increase communication, knowledge, and use of contraception among teens and their peers, according to a recently published study.

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related to this article

October 29th, 2026

Susan Reed, MD, on the future of menopause research and funding

Susan Reed, MD, on the need for menopause research funding, a clinical trials network, and studies in understudied groups and perimenopause.

October 29th, 2026

Chrisandra Shufelt, MD, on cardiovascular prevention at menopause

Chrisandra Shufelt, MD, on why menopause is a window for cardiovascular prevention and the risk factors OB/GYNs should assess.

October 28th, 2026

Matthew Nudy, MD, on estrogen and the cardiovascular system

Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.

October 28th, 2026

ACOG advises against GLP-1 receptor agonists during pregnancy

ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.

October 27th, 2026

Rhonda Voskuhl, MD, on estriol for cognitive symptoms of menopause

Rhonda Voskuhl, MD, on a case series in which estriol and progesterone improved self-reported cognition in menopausal women at 12 months.

October 27th, 2026

Multi-society framework ties cardiovascular risk to female life stages

Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.

October 26th, 2026

Mind, Body, & the Pause: Menopause, brain fog, and screening gaps, with Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG

In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.